Your browser doesn't support javascript.
loading
Acinetobactin-Mediated Inhibition of Commensal Bacteria by Acinetobacter baumannii.
Knauf, Gregory A; Powers, Matthew J; Herrera, Carmen M; Trent, M Stephen; Davies, Bryan W.
Afiliação
  • Knauf GA; Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
  • Powers MJ; Center for Systems and Synthetic Biology, John Ring LaMontagne Center for Infectious Diseases, University of Texas at Austin, Austin, Texas, USA.
  • Herrera CM; Department of Microbiology, College of Arts and Sciences, University of Georgiagrid.213876.9, Athens, Georgia, USA.
  • Trent MS; Department of Infectious Diseases, University of Georgiagrid.213876.9, Athens, Georgia, USA.
  • Davies BW; Department of Microbiology, College of Arts and Sciences, University of Georgiagrid.213876.9, Athens, Georgia, USA.
mSphere ; 7(1): e0001622, 2022 02 23.
Article em En | MEDLINE | ID: mdl-35138126
Acinetobacter baumannii is an important hospital-associated pathogen that causes antibiotic resistant infections and reoccurring hospital outbreaks. A. baumannii's ability to asymptomatically colonize patients is a risk factor for infection and exacerbates its spread. However, there is little information describing the mechanisms it employs to colonize patients. A. baumannii often colonizes the upper respiratory tract and skin. Antibiotic use is a risk factor for colonization and infection suggesting that A. baumannii likely competes with commensal bacteria to establish a niche. To begin to investigate this possibility, we cocultured A. baumannii and commensal bacteria of the upper respiratory tract and skin. In conditions that mimic iron starvation experienced in the host, we observed that A. baumannii inhibits Staphylococcus epidermidis, Staphylococcus hominis, Staphylococcus haemolyticus and Corynebacterium striatum. Then using an ordered transposon library screen we identified the A. baumannii siderophore acinetobactin as the causative agent of the inhibition phenotype. Using mass spectrometry, we show that acinetobactin is released from A. baumannii under our coculture conditions and that purified acinetobactin can inhibit C. striatum and S. hominis. Together our data suggest that acinetobactin may provide a competitive advantage for A. baumannii over some respiratory track and skin commensal bacteria and possibly support its ability to colonize patients. IMPORTANCE The ability of Acinetobacter baumannii to asymptomatically colonize patients is a risk factor for infection and exacerbates its clinical spread. However, there is minimal information describing how A. baumannii asymptomatically colonizes patients. Here we provide evidence that A. baumannii can inhibit the growth of many skin and upper respiratory commensal bacteria through iron competition and identify acinetobactin as the molecule supporting its nutritional advantage. Outcompeting endogenous commensals through iron competition may support the ability of A. baumannii to colonize and spread among patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acinetobacter baumannii Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: MSphere Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acinetobacter baumannii Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: MSphere Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos